Two Sigma Investments’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-940
Closed -$8.04K 3435
2023
Q3
$8.04K Hold
940
﹤0.01% 2906
2023
Q2
$7.57K Buy
940
+431
+85% +$3.14K ﹤0.01% 2951
2023
Q1
$2.98K Sell
509
-2,937
-85% -$15.7K ﹤0.01% 2916
2022
Q4
$14.5K Sell
3,446
-8,725
-72% -$41K ﹤0.01% 2708
2022
Q3
$66K Buy
+12,171
New +$232K ﹤0.01% 2279
2021
Q1
Sell
-577
Closed -$38K 4337
2020
Q4
$38K Buy
+577
New +$27.6K ﹤0.01% 3261
2018
Q4
Sell
-626
Closed -$36K 3635
2018
Q3
$36K Buy
626
+243
+63% +$15.4K ﹤0.01% 3106
2018
Q2
$29K Buy
+383
New +$30.8K ﹤0.01% 3239

Other funds holding NTBL

Two Sigma Investments's NTBL Position: Q4 2023 in Review

Two Sigma Investments sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2023, closing a stake of 940 shares — an estimated $8.04K sold.

Two Sigma Investments first reported a position in NTBL in Q2 2018 and held it in 8 quarters. The position peaked at $66K in Q3 2022. 12 funds tracked by Wall St. Rank hold NTBL as of Q4 2023.

  • Two Sigma Investments reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Investments sold 940 Notable Labs, Ltd. Ordinary Shares shares in Q4 2023, an estimated $8.04K.
  • Two Sigma Investments first reported a position in Notable Labs, Ltd. Ordinary Shares in Q2 2018 and held it in 8 quarters.
  • Two Sigma Investments's Notable Labs, Ltd. Ordinary Shares position peaked at $66K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.